National Asset Management Boosted Johnson & Johnson (JNJ) Position; SANUWAVE HEALTH (SNWV) Shorts Lowered By 98.12%

February 18, 2018 - By Linda Rogers

SANUWAVE HEALTH INCORPORATED (OTCMKTS:SNWV) had a decrease of 98.12% in short interest. SNWV’s SI was 600 shares in February as released by FINRA. Its down 98.12% from 32,000 shares previously. The stock increased 2.00% or $0.005 during the last trading session, reaching $0.255. About 214,304 shares traded. SANUWAVE Health, Inc. (OTCMKTS:SNWV) has 0.00% since February 18, 2017 and is . It has underperformed by 16.70% the S&P500.

National Asset Management Inc increased Johnson & Johnson (JNJ) stake by 5.78% reported in 2017Q3 SEC filing. National Asset Management Inc acquired 2,940 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The National Asset Management Inc holds 53,766 shares with $6.99 million value, up from 50,826 last quarter. Johnson & Johnson now has $357.71 billion valuation. The stock increased 1.46% or $1.92 during the last trading session, reaching $133.15. About 7.97 million shares traded or 6.53% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since February 18, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic pressure shockwaves for regenerative medicine and other applications. The company has market cap of $35.51 million. The Company’s shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It currently has negative earnings. The companyÂ’s lead product candidate is the dermaPACE device, which has completed its initial Phase III, IDE clinical trial for treating diabetic foot ulcers.

Investors sentiment is 0.83 in Q3 2017. Its the same as in 2017Q2. It is flat, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Raab And Moskowitz Asset Mgmt Llc has invested 2.9% in Johnson & Johnson (NYSE:JNJ). Wellcome Tru Ltd (The) As Trustee Of The Wellcome Tru has 3.53% invested in Johnson & Johnson (NYSE:JNJ). Security Bancorp Of Sioux City Iowa Ia invested in 2.44% or 19,182 shares. Phocas Corporation has invested 0.17% in Johnson & Johnson (NYSE:JNJ). Baltimore has invested 2.37% in Johnson & Johnson (NYSE:JNJ). Brown Capital Limited Liability invested in 0% or 2,437 shares. Pathstone Family Office Limited Liability invested 0.44% of its portfolio in Johnson & Johnson (NYSE:JNJ). Sprucegrove Management stated it has 221,900 shares. Holowesko Prns Limited invested in 3.04% or 293,900 shares. Bank & Trust Pictet & Cie (Asia) Ltd holds 4.75% or 77,500 shares. Community National Bank Na invested in 1.18% or 82,138 shares. Vision Mngmt Inc invested in 0.75% or 18,092 shares. Bartlett Comm has 1.07% invested in Johnson & Johnson (NYSE:JNJ) for 196,371 shares. Moreover, Carnegie Asset Lc has 1.69% invested in Johnson & Johnson (NYSE:JNJ). Ballentine Prns Ltd Liability accumulated 26,397 shares.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 89 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Tuesday, September 29 by Deutsche Bank. Jefferies maintained Johnson & Johnson (NYSE:JNJ) on Thursday, July 14 with “Hold” rating. As per Friday, July 21, the company rating was downgraded by Atlantic Securities. Piper Jaffray reinitiated the stock with “Neutral” rating in Monday, October 5 report. On Friday, December 18 the stock rating was initiated by Atlantic Securities with “Neutral”. The rating was maintained by BMO Capital Markets on Tuesday, October 17 with “Buy”. The firm earned “Buy” rating on Wednesday, October 18 by Wells Fargo. The firm has “Buy” rating by Jefferies given on Tuesday, January 16. The firm has “Hold” rating given on Friday, June 16 by Jefferies. As per Wednesday, April 20, the company rating was maintained by Argus Research.

National Asset Management Inc decreased Sanofi (NYSE:SNY) stake by 6,159 shares to 18,862 valued at $940,000 in 2017Q3. It also reduced Ishares Tr (ITOT) stake by 9,952 shares and now owns 113,182 shares. Cvs Health Corp (NYSE:CVS) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.